Based on these results, in 2004, the FDA approved the Merci Retrieval System to remove clots from vessels in patients experiencing an ischemic stroke ineligible for intravenous thrombolytics or as a rescue therapy after unsuccessful recanalization with tPA. This evidence concerns the gene PLAT and ischemic stroke.